Novo Nordisk A/S Share Price

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen 08:50:00 14/06/2024 pm IST 5-day change 1st Jan Change
991 DKK +1.15% Intraday chart for Novo Nordisk A/S +0.71% +41.96%

Financials

Sales 2024 * 291B 41.8B 3,491B Sales 2025 * 352B 50.49B 4,217B Capitalization 4,396B 631B 52,673B
Net income 2024 * 105B 15.02B 1,255B Net income 2025 * 128B 18.33B 1,531B EV / Sales 2024 * 15.2 x
Net Debt 2024 * 22.09B 3.17B 265B Net cash position 2025 * 6.04B 866M 72.32B EV / Sales 2025 * 12.5 x
P/E ratio 2024 *
42.4 x
P/E ratio 2025 *
34.5 x
Employees 66,015
Yield 2024 *
1.2%
Yield 2025 *
1.47%
Free-Float 70.17%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.15%
1 week+0.71%
Current month+6.87%
1 month+8.06%
3 months+9.62%
6 months+49.29%
Current year+41.96%
More quotes
1 week
977.00
Extreme 977
997.40
1 month
900.00
Extreme 900
997.40
Current year
688.80
Extreme 688.8
997.40
1 year
504.40
Extreme 504.4
997.40
3 years
252.90
Extreme 252.9
997.40
5 years
156.00
Extreme 156
997.40
10 years
109.10
Extreme 109.1
997.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 01/91/01
Director of Finance/CFO 53 01/99/01
Chief Tech/Sci/R&D Officer - 01/15/01
Members of the board TitleAgeSince
Director/Board Member 62 19/15/19
Chairman 61 23/17/23
Director/Board Member 68 01/18/01
More insiders
Date Price Change Volume
14/24/14 991 +1.15% 2,230,542
13/24/13 979.7 -1.00% 1,849,236
12/24/12 989.6 +0.77% 1,875,917
11/24/11 982 -0.65% 2,681,162
10/24/10 988.4 +0.45% 1,956,865

Delayed Quote Nasdaq Copenhagen, June 14, 2024 at 08:50 pm IST

More quotes
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
991 DKK
Average target price
934.3 DKK
Spread / Average Target
-5.72%
Consensus
  1. Stock Market
  2. Equities
  3. NOVO B Stock